评估自费双参数前列腺MRI项目的下游收入
本研究量化了自费双参数前列腺MRI(bpMRI)项目的下游医疗利用与收入,回顾592例患者记录,按MRI病灶与前列腺切除术情况分四组。每例bpMRI患者下游收入保守估计为520美元,A组贡献47%总收入(每例1974美元),A、B组为泌尿外科主要收入来源,C组为放射肿瘤科主要来源,D组为放射科主要来源。结论认为自费bpMRI项目有潜力在财务可持续的同时改善前列腺癌筛查可及性。
要点
- 每例接受bpMRI的患者下游收入保守估计为520美元。
- A组(有病灶且行前列腺切除术)贡献47%总收入,每例1974美元。
- A、B组为泌尿外科主要相对收入来源,C组为放射肿瘤科,D组为放射科。
核心结论
- 自费bpMRI项目有潜力在保持财务可持续的同时改善患者接受前列腺癌筛查的可及性。
研究设计与样本
- 回顾性分析2017年8月至2020年3月间接受bpMRI的592例患者的病历,追踪随访临床活动。
- 临床活动包括前列腺活检、根治性前列腺切除术、外照射放疗、近距离放疗、雄激素剥夺治疗、胸部腹部盆腔CT、PET/CT、盆腔MRI和核医学骨扫描。
- 费用取自Medicare Physician Fee Schedule以保守估计收入。
- 患者分为四组:A组有MRI病灶且行前列腺切除术;B组无病灶但行前列腺切除术;C组有病灶但未行前列腺切除术;D组无病灶且未行前列腺切除术。
- 收入按泌尿外科、放射肿瘤科和放射科亚专科分类。
主要发现
- 保守估计每例接受bpMRI的患者下游收入为520美元。
- A组患者贡献总收入的47%,每例1974美元。
- B组为最小分组,每例1828美元。
- C组为最大分组,每例398美元。
- D组每例收入最低,为179美元。
关键数值与推荐
- A组和B组为泌尿外科贡献最多相对收入。
- C组为放射肿瘤科贡献最多相对收入。
- D组为放射科贡献最多相对收入。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To quantify downstream healthcare utilization and revenue associated with a self-pay bi-parametric prostate MRI (bpMRI) program. METHODS: Medical records of 592 patients who underwent bpMRI between August 2017 and March 2020 were examined for follow-up clinical activities. These include prostate biopsy, radical prostatectomy, external beam radiation therapy, brachytherapy, androgen deprivation therapy, CT Chest, Abdomen and Pelvis, PET/CT, MRI Pelvis, and Nuclear Medicine Bone Scans. The charges for each clinical activity were derived from the Medicare Physician Fee Schedule to conservatively estimate revenues. This patient population was further divided into four groups: Group A, patients who demonstrated an MRI lesion and underwent prostatectomy; Group B, patients who did not demonstrate lesion but underwent prostatectomy; Group C, patients who demonstrated lesion but did not undergo prostatectomy; and Group D, patients who neither demonstrated lesion nor underwent prostatectomy. Revenues for each group were categorized by Urology, Radiation Oncology and Radiology subspecialties. RESULTS: Conservative estimates yielded $520 of downstream revenue per patient who underwent bpMRI. Group A patients yielded 47% of total revenue ($1974 per patient). Group B patients, the smallest group, yielded $1828 per patient. Group C patients made up the largest group and grossed $398 per patient. Group D demonstrated the lowest per patient revenue of $179. Groups A and B yielded most relative revenue for Urology. Group C yielded most relative revenue for Radiation Oncology, and Group D yielded most relative revenue for Radiology. CONCLUSION: A self-pay bpMRI program has the potential to improve patient access to prostate cancer screening while remaining financial sustainable.
引用
- Parikh KD, Declouette B, Chen M, et al. Evaluating the Downstream Revenues of a Self-Pay Bi-Parametric Prostate MRI Program. Urology. 2022. PMID: 36195163. doi:10.1016/j.urology.2022.09.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。